Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

T. Iwase · SciRah

Researcher profile · Semantic Scholar

T. Iwase

Share profile

T. Iwase — researcher profile on SciRah

h-index: 15
Works: 66
Citations: 762

Most-cited papers

Small, polypoid-appearing carcinoid tumors of the rectum: clinicopathologic study of 16 cases and effectiveness of endoscopic treatment.
K. Matsui, T. Iwase, M. Kitagawa
1993American Journal of Gastroenterology117 citations
Semantic Scholar
Impact of body fat distribution on neoadjuvant chemotherapy outcomes in advanced breast cancer patients
T. Iwase, T. Sangai, T. Nagashima, M. Sakakibara +5 more
2015Cancer Medicine94 citations Open access
Semantic Scholar
Body composition and breast cancer risk and treatment: mechanisms and impact
T. Iwase, Xiaoping Wang, T. Shrimanker, Mikhail G. Kolonin +1 more
2021Breast Cancer Research and Treatment85 citations
Semantic Scholar
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer
Xiaoping Wang, T. Semba, G. Manyam, Jing Wang +20 more
2022Science Advances65 citations Open access
Semantic Scholar
An increased neutrophil-to-lymphocyte ratio predicts poorer survival following recurrence for patients with breast cancer.
T. Iwase, T. Sangai, M. Sakakibara, J. Sakakibara +6 more
2017Molecular and clinical oncology46 citations Open access
Semantic Scholar
Quality and quantity of visceral fat tissue are associated with insulin resistance and survival outcomes after chemotherapy in patients with breast cancer
T. Iwase, T. Sangai, H. Fujimoto, Yuji Sawabe +7 more
2019Breast Cancer Research and Treatment39 citations
Semantic Scholar
A Novel Immunomodulatory 27-Gene Signature to Predict Response to Neoadjuvant Immunochemotherapy for Primary Triple-Negative Breast Cancer
T. Iwase, K. Blenman, Xiaotong Li, Emily S. Reisenbichler +9 more
2021Cancers35 citations Open access
Semantic Scholar
Targeting Signaling Pathways in Inflammatory Breast Cancer
Xiaoping Wang, T. Semba, Lan Phi, S. Chainitikun +3 more
2020Cancers35 citations Open access
Semantic Scholar
A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment
B. Lim, R. Murthy, Jangsoon Lee, S. Jackson +18 more
2019British Journal of Cancer26 citations Open access
Semantic Scholar
Phase II study of Radium‐223 dichloride combined with hormonal therapy for hormone receptor‐positive, bone‐dominant metastatic breast cancer
N. Ueno, Rie K. Tahara, T. Fujii, J. Reuben +12 more
2019Cancer Medicine26 citations Open access
Semantic Scholar
The effect of molecular subtype and body mass index on neo-adjuvant chemotherapy in breast cancer patients.
T. Iwase, R. Nakamura, N. Yamamoto, Atushi Yoshi +2 more
2014Breast23 citations Open access
Semantic Scholar
PI3K and MAPK Pathways as Targets for Combination with the Pan-HER Irreversible Inhibitor Neratinib in HER2-Positive Breast Cancer and TNBC by Kinome RNAi Screening
Jangsoon Lee, Huey Liu, T. Pearson, T. Iwase +7 more
2021Biomedicines19 citations Open access
Semantic Scholar
Changes in Overall Survival over Time for Patients with de novo Metastatic Breast Cancer
T. Iwase, T. Shrimanker, Rubén Rodríguez-Bautista, O. Şahin +4 more
2021Cancers18 citations Open access
Semantic Scholar
Impact of change in body mass index during neoadjuvant chemotherapy and survival among breast cancer subtypes
T. Kogawa, T. Fujii, T. Fouad, Diane D. Liu +9 more
2018Breast Cancer Research and Treatment17 citations
Semantic Scholar
Volumetric breast density is essential for predicting cosmetic outcome at the late stage after breast-conserving surgery.
Nobumitsu Shiina, M. Sakakibara, Kaoru Fujisaki, T. Iwase +6 more
2016European Journal of Surgical Oncology15 citations
Semantic Scholar
The Prognostic Impact of Body Composition for Locally Advanced Breast Cancer Patients Who Received Neoadjuvant Chemotherapy
T. Iwase, Aaroh M. Parikh, S. Dibaj, Yu Shen +9 more
2021Cancers14 citations Open access
Semantic Scholar
The Relationship Between Skeletal-Related Events and Bone Scan Index for the Treatment of Bone Metastasis With Breast Cancer Patients
T. Iwase, N. Yamamoto, Hironori Ichihara, T. Togawa +2 more
2014Medicine12 citations Open access
Semantic Scholar
Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC
T. Iwase, K. Harano, H. Masuda, K. Kida +10 more
2020BMC Cancer9 citations Open access
Semantic Scholar
Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines
Xuemei Xie, Jangsoon Lee, T. Iwase, M. Kai +1 more
2022Expert opinion on therapeutic targets8 citations Open access
Semantic Scholar
The efficacy of first-line chemotherapy in endocrine-resistant hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer.
S. Chainitikun, J. Long, Rubén Rodríguez-Bautista, T. Iwase +3 more
2020Breast Cancer Research and Treatment8 citations Open access
Semantic Scholar
Maintenance pembrolizumab therapy in patients with metastatic HER2-negative breast cancer with prior response to chemotherapy
T. Iwase, Evan N Cohen, Hui Gao, Angela Alexander +17 more
2024Clinical Cancer Research7 citations
Semantic Scholar
Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines
Xuemei Xie, Jangsoon Lee, J. Fuson, Huey Liu +5 more
2023Biomedicines7 citations Open access
Semantic Scholar
Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review
S. Chainitikun, J. R. Espinosa Fernández, J. Long, T. Iwase +6 more
2021PLoS ONE6 citations Open access
Semantic Scholar
Advanced small-cell colon carcinoma: a case report
T. Iwase, Y. Masuda, Takayuki Suzuki, O. Takahashi +1 more
2013Journal of Medical Case Reports5 citations Open access
Semantic Scholar
TGIRT-seq of Inflammatory Breast Cancer Tumor and Blood Samples Reveals Widespread Enhanced Transcription Impacting RNA Splicing and Intronic RNAs in Plasma
D. Wylie, Xiaoping Wang, Jun Yao, Hengyi Xu +5 more
2023medRxiv4 citations Open access
Semantic Scholar
Neoadjuvant HER2-targeted regimens with or without anthracyclines for HER2-positive inflammatory breast cancer: a multicenter retrospective study
T. Iwase, Nithya Sridhar, M. Kai, W. Dong +15 more
2025Breast Cancer Research and Treatment3 citations
Semantic Scholar
Reassessing estrogen receptor expression thresholds for breast cancer prognosis in HER2-negative patients using shape restricted modeling
W. Dong, T. Fujii, Jing Ning, T. Iwase +3 more
2025Scientific Reports3 citations Open access
Semantic Scholar
Circulating cancer-associated macrophage-like cells and macrophage-related cytokines in obese patients with advanced breast cancer who undergo neoadjuvant chemotherapy
T. Iwase, Aaroh M. Parikh, Wen-Li Dong, Yu Shen +15 more
2024Journal of Cancer3 citations Open access
Semantic Scholar
Abstract P3-02-04: Phase II study of Pembrolizumab Maintenance treatment in patients with HER2-negative inflammatory breast cancer (IBC) and triple-negative breast cancer (TNBC) after response to chemotherapy
T. Iwase, Angela Alexander, Vivian Chiv, M. Kai +18 more
2023Cancer Research2 citations
Semantic Scholar
Validation of Prognostic Stage and Anatomic Stage in the American Joint Committee on Cancer 8th Edition for Inflammatory Breast Cancer
K. Kida, K. Hess, B. Lim, T. Iwase +9 more
2020Cancers2 citations Open access
Semantic Scholar
Validation of an immunomodulatory gene signature algorithm to predict response to neoadjuvant immunochemotherapy in patients with primary triple-negative breast cancer.
T. Iwase, L. Pusztai, K. Blenman, Xiaotong Li +8 more
20202 citations
Semantic Scholar
A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment
B. Lim, R. Murthy, Jangsoon Lee, S. Jackson +18 more
2019British Journal of Cancer2 citations Open access
Semantic Scholar
Phase II study of neoadjuvant anthracycline combined with nanoparticle albumin-bound paclitaxel for human epidermal growth factor receptor 2-negative breast cancer.
Emi Ishigami, M. Sakakibara, J. Sakakibara, T. Iwase +7 more
2017Molecular and clinical oncology2 citations Open access
Semantic Scholar
Abstract P4-02-26: Quantitative estrogen receptor expression affects pathologic complete response to neoadjuvant chemotherapy in patients with early-stage breast cancer with low expression of HER2
T. Iwase, T. Fujii, C. Yam, W. Dong +3 more
2023Cancer Research1 citations
Semantic Scholar
Reassessing Estrogen Receptor Expression Thresholds for Breast Cancer Prognosis in HER2-negative Patients Using Shape Restricted Modeling
W. Dong, T. Fujii, Jing Ning, T. Iwase +3 more
2023Research Square1 citations Open access
Semantic Scholar
Abstract PD10-08: Remodeling the inflammatory breast cancer tumor microenvironment to enhance immunotherapy: Novel therapeutic development
Xiaoping Wang, T. Semba, G. Manyam, Jing Wang +17 more
2022Cancer Research1 citations
Semantic Scholar
The efficacy of first-line chemotherapy in endocrine-resistant hormone receptor-positive (HR+), human epidermal growth factor receptor 2- negative (HER2-) metastatic breast cancer (MBC).
S. Chainitikun, J. Long, Rubén Rodríguez-Bautista, T. Iwase +3 more
2020Journal of Clinical Oncology1 citations
Semantic Scholar
[The Case of a Patient with Invasive Lobular Carcinoma with Solitary Metastasis in Pectoralis Major Muscle].
T. Iwase, T. Sangai, M. Sakakibara, T. Nagashima +5 more
2015Gan to kagaku ryoho. Cancer & chemotherapy1 citations
Semantic Scholar
[Long-Term Outcome of Radiofrequency Ablation Therapy for Breast Cancer].
T. Nagashima, M. Sakakibara, T. Sangai, J. Sakakibara +6 more
2015Gan to kagaku ryoho. Cancer & chemotherapy1 citations
Semantic Scholar
A CASE OF MALIGNANT LYMPHOMA DIAGNOSED WITH SPONTANEOUS TUMOR PERFORATION
Toru Saito, S. Nozawa, H. Nagai, T. Iwase +2 more
20101 citations Open access
Semantic Scholar
Advances in targets in inflammatory breast cancer.
T. Iwase, Xiaoping Wang, Lan Thi Hanh Phi, Nithya Sridhar +2 more
2024International Review of Cell and Molecular Biology0 citations
Semantic Scholar
Sequential monitoring of tumor macrophage fusion cells in the circulation of metastatic breast cancer and their prognostic value.
K. Gardner, M. Cristofanilli, C. Reduzzi, R. Alpaugh +8 more
2023Journal of Clinical Oncology0 citations Open access
Semantic Scholar
Clinical utility of a novel non-invasive technology for monitoring severe neutropenia in anticancer therapy.
M. Alva Bianchi, T. Iwase, P. Tolosa Ortega, Pablo Justo Jiménez +16 more
2023Journal of Clinical Oncology0 citations Open access
Semantic Scholar
Abstract P4-07-14: Long-term Outcomes After 1 or 2-3 Lines of Neoadjuvant Therapy in Stage III Inflammatory Breast Cancer
F. Nakhlis, S. Niman, N. Ueno, Elizabeth P. Troll +16 more
2023Cancer Research0 citations
Semantic Scholar
Correlation of micronuclei formation in circulating stromal cells with their PD-L1 expression and predicts for poorer clinical outcomes in metastatic breast cancer.
Dimpal M Kasabwala, M. Cristofanilli, R. Alpaugh, S. Chumsri +7 more
2023Journal of Clinical Oncology0 citations
Semantic Scholar
Abstract P5-06-06: TROP2 and HER2 expression by liquid biopsy in women with mTNBC
David Bourdon, Alessandra Cunsolo, Brandon Guillory, Megan M. Slade +4 more
2023Cancer Research0 citations
Semantic Scholar
Biomarker analysis of phase II pembrolizumab maintenance treatment after chemotherapy response in patients with HER2-negative inflammatory breast cancer and triple-negative breast cancer.
T. Iwase, Angela Alexander, E. Cohen, Hui Gao +16 more
2023Journal of Clinical Oncology0 citations Open access
Semantic Scholar
Clinical outcomes after 1 versus 2-3 lines of neoadjuvant therapy in stage III inflammatory breast cancer
F. Nakhlis, S. Niman, Naoto T. Ueno, Elizabeth P. Troll +16 more
2023Breast Cancer Research and Treatment0 citations
Semantic Scholar
Abstract P5-07-03: Disease classification modeling of inflammatory breast cancer based on simultaneous profiling of coding and non-coding RNAs in tumor and blood samples by TGIRT-sequencing
D. Wylie, Xiaoping Wang, Jun Yao, Heng-Yi Xu +4 more
2022Cancer Research0 citations
Semantic Scholar
Abstract PS2-23: Prospective study of circulating cancer-associated macrophage-like cells (CAMLs) in obese patients with advanced breast cancer
T. Iwase, Aaroh M. Parikh, O. Şahin, A. Raghavendra +10 more
20210 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

N. Ueno×31
Invite
N. Ueno — researcher profile on SciRah
D. Tripathy×14
Invite
D. Tripathy — researcher profile on SciRah
Xiaoping Wang×9
Invite
Xiaoping Wang — researcher profile on SciRah
B. Lim×9
Invite
B. Lim — researcher profile on SciRah

×9

Invite

K. Kida — researcher profile on SciRah

T. Nagashima×8

Invite

T. Nagashima — researcher profile on SciRah

S. Krishnamurthy×8

Invite

S. Krishnamurthy — researcher profile on SciRah

S. Chainitikun×8

Invite

S. Chainitikun — researcher profile on SciRah

Invite

Yu Shen — researcher profile on SciRah

Invite

T. Sangai — researcher profile on SciRah

Invite

T. Fujii — researcher profile on SciRah

M. Sakakibara×6

Invite

M. Sakakibara — researcher profile on SciRah